RYTM vs SEPN Stock Comparison
SEPN currently leads RYTM in this stock comparison, with AIQ scores of 69 vs 62. The clearest difference is momentum, while RYTM has the stronger risk resilience profile.
What is the main difference between RYTM and SEPN?
SEPN leads the current stock comparison as Septerna Inc, with the clearest separation coming from momentum and the broader AIQ evidence mix.
AlgovestIQ AIQ Comparison
Rhythm Pharmaceuticals, Inc. vs Septerna Inc
SEPN leads
SEPN leads by 7 AIQ points, primarily on Momentum and Quality, but the lead has narrowed from 19 points over 30 sessions.
Fragile: 1 of 5 evidence groups support SEPN, its lead is narrowing, and its current signal state is conflicted.
Rhythm Pharmaceuticals, Inc.
Septerna Inc
The Algovestiq AIQ Score currently favors SEPN over RYTM, 69 versus 62 as of Nov 15, 2026. SEPN's advantage is driven primarily by stronger momentum and quality, while RYTM holds the stronger risk resilience profile. SEPN also shows the weaker technical structure relative to its 50-day moving average. 1 of 5 covered evidence groups favor SEPN today, and the comparison is rated Fragile on stability: only 1 of 5 covered evidence groups agree. SEPN lead: Weakening — the AIQ differential moved from 19 to 7 points over 30 sessions.
Compare Rhythm Pharmaceuticals, Inc. and Septerna Inc across the Algovestiq AIQ Score, valuation, quality, momentum, risk, technicals and analyst expectations.
Performance over time
Price return from daily closes; distributions are not included.
Price return comparison
Growth of $10,000, price only
Split-adjusted closes only. Distributions are excluded, which understates the return of any fund or stock that pays them.
Compare RYTM and SEPN against another ticker
Open a multi-ticker workspace without changing this focused pair page.
AIQ Factor Divergence
Where the two separate, on the four dimensions behind the AIQ Score. Bars read outward from a shared zero: further from the centre is a wider gap.
- Momentum72 vs 87SEPN +15
- Quality60 vs 66SEPN +6
- Risk Resilience57 vs 52RYTM +5
- Value52 vs 55Even
1 of 5 evidence groups favor SEPN. SEPN’s edge is concentrated in momentum and quality; RYTM keeps a meaningful risk resilience edge.
What changed since the last close
Latest scored session 2026-11-13, compared against the prior scored session 2026-11-12.
Largest factor move: Momentum +4
New signals
- ADX Trend Strengthening — neutral, trend, medium horizon
Largest factor move: Quality +1, not enough on its own to move the overall score.
New signals
- Low Volume Rally Warning — bearish, volume, short horizon (0.79x)
- MACD Bearish Crossover — bearish, momentum, short horizon
- MACD Histogram Expanding Bearish — bearish, momentum, short horizon
SEPN's lead narrowed by 2 AIQ points in the latest session.
Deeper signal detail for each name lives on its own signals page — RYTM and SEPN both carry a full feed there.
The central trade-off
SEPN (Septerna Inc): the stronger current systematic profile, led by momentum and quality.
RYTM (Rhythm Pharmaceuticals, Inc.): the counter-case, on risk resilience, fundamentals, technicals — but at materially higher volatility, 110.9% against 81.8%.
Which one fits your objective
The same two names rank differently depending on what you are optimizing for. All six reads are shown at once — none of them is hidden behind a toggle.
Balanced
SEPNSEPN on the overall AIQ Score, which weights Quality and Value most heavily.
Growth
RYTMRYTM on combined revenue and EPS growth.
Value
EvenThe two are level on Value.
Momentum
SEPNSEPN on the Momentum factor, by 15 points.
Lower downside
RYTMRYTM on Risk Resilience, by 5 points.
Analyst upside
EvenAnalyst targets are level or not covered for both names.
AIQ vs Wall Street
Where the systematic read and the analyst consensus line up — and where they do not.
| Measure | RYTM | SEPN | Note |
|---|---|---|---|
| Implied upside to target | +18.5% | — | Level |
| Target dispersion | +28.6% | — | Lower is tighter analyst agreement |
| Consensus | Buy | Buy | Context, not a primary driver |
| Analysts covering | 19 | 10 | Higher coverage generally improves confidence |
Analyst targets are expectations, not predictions. Dispersion matters as much as the midpoint.
AIQ Agreement Matrix
1 of 5 covered evidence groups favor SEPN. A wide gap backed by one group is a weaker case than a narrow gap backed by five.
| Evidence group | Favors | Reading |
|---|---|---|
| AIQ Score | SEPN | 62 vs 69 |
| Fundamentals | RYTMon balance | revenue growth 29.3% vs -29.4%; EPS growth 16.4% vs -96.6%; TTM ROE -20.5% vs -6.2%; gross margin 88.2% vs 99.6%; operating margin -66.7% vs -76.2% — RYTM takes 3 of 5 decided legs, not all of them |
| Valuation | Even | Value 52 vs 55 |
| Technicals | RYTM | Price vs 50-day 18.7% vs 5.3%; vs 200-day 18.3% vs 28.6% |
| Risk Resilience | RYTM | Risk Resilience 57 vs 52 |
| Analyst expectations | Not covered | Not covered |
✓ agrees with the overall verdict · ✕ points the other way. Groups marked “not covered” lack data on one or both of RYTM and SEPN and are excluded from the count.
AIQ Decision Stability
The conclusion is sensitive to small changes. Treat the lead as provisional and watch the flip conditions below.
- The AIQ gap is moderate at 7 points.
- Only 1 of 5 covered evidence groups agree. (argues the conclusion is provisional)
- The leader's advantage has been narrowing. (argues the conclusion is provisional)
- The leader is throwing conflicting signals. (argues the conclusion is provisional)
Stability combines the score gap, how broadly the evidence agrees, how steady the lead has been across daily snapshots, the current signal state on both names, and analyst dispersion on SEPN.
How the comparison changed
120 daily snapshots · May 27 – Nov 13SEPN lead: Weakening — the AIQ differential moved from 19 to 7 points over 30 sessions.
- Today
- SEPN +7
- 62 vs 69
- 7 sessions ago
- SEPN +19
- 57 vs 76
- 30 sessions ago
- SEPN +19
- 55 vs 74
- 90 sessions ago
- SEPN +13
- 62 vs 75
The lead has not changed hands in this window.
AIQ Signal Divergence
Only the signals that bear on the head-to-head. A conflicted name is carrying bullish and bearish rules at the same time — the technical evidence is not pointing one way.
3 bullish / 3 bearish / 2 neutral, conflicted
Only RYTM
- Death Cross Active — bearish, trend, long horizon (0.37%)
- ADX Trend Strengthening — neutral, trend, medium horizon
- Beta Spike Warning — bearish, risk_regime, long horizon
- Keltner Channel Breakout — bullish, volatility, short horizon
- TRIX Bullish Signal — bullish, momentum, short horizon
3 bullish / 3 bearish / 2 neutral, conflicted
Only SEPN
- Golden Cross Active — bullish, trend, long horizon (22.16%)
- ADX Trend Weakening — neutral, trend, medium horizon
- MACD Bearish Crossover — bearish, momentum, short horizon
- MACD Histogram Expanding Bearish — bearish, momentum, short horizon
- Uptrend Structure Active — bullish, trend, long horizon
Both carry 3 more signals that do not separate them: ATR Expansion - Breakout Mode, EMA Ribbon Expansion Bullish, Low Volume Rally Warning.
SEPN leads the comparison while carrying a conflicted signal state, which is one reason the stability rating is not higher.
Price vs model alignment
Whether the latest session's price move confirms what the model did over the same session, or contradicts it.
Price and the AIQ Score both moved up over the latest session (price +4.7%, AIQ +2 points).
Neither the price nor the AIQ Score moved enough in the latest session to confirm or contradict the other (price +1.77%, AIQ 0 points).
What would flip this result
A state, not a forecast. These are the specific, observable changes that would reverse the verdict — not a price prediction.
- 1RYTM closes the Momentum gap — currently 15 points behind, the largest single contributor to SEPN's edge.
- 2RYTM's Death Cross Active resolves — a bearish trend rule currently active against it.
- 3SEPN's conflicting signal state resolves bearish — it currently carries 3 bullish and 3 bearish rules at once.
- 4The narrowing continues — the lead has already given back 12 points over 30 sessions, and a further 7-point move would eliminate SEPN's advantage entirely.
The full evidence
Every number behind the verdict. The leader is called above each group so you are not left to solve it from the table.
Fundamentals
RYTM leads on balance| Metric | RYTM | SEPN |
|---|---|---|
| Revenue growth (YoY) | 29.3% | -29.4% |
| EPS growth (YoY) | 16.4% | -96.6% |
| Gross margin | 88.2% | 99.6% |
| Operating margin | -66.7% | -76.2% |
| Return on equity (TTM) | -20.5% | -6.2% |
| Debt to equity | 0.02 | 0.05 |
Performance
Split across windows| Metric | RYTM | SEPN |
|---|---|---|
| 1 week (5 sessions) | 2.4% | -12.8% |
| 1 month (20 sessions) | 33.5% | 17.2% |
| 3 months (63 sessions) | -0.4% | -3.6% |
| 6 months (126 sessions) | 27.1% | 58.1% |
| Year to date | 7.5% | 52.8% |
| 1 year (252 sessions) | 17.5% | 121.5% |
Technicals
RYTM has the stronger structure| Metric | RYTM | SEPN |
|---|---|---|
| RSI (14) | 66.3 | 48 |
| ADX (14) | 28.5 | 18.1 |
| Price vs 50-day | 18.7% | 5.3% |
| Price vs 200-day | 18.3% | 28.6% |
| Volatility (1M, annualized) | 110.9% | 81.8% |
Risk
RYTM is the more resilient| Metric | RYTM | SEPN |
|---|---|---|
| Beta | 1.24 | 1.01 |
| Sharpe ratio | 0.52 | 1.43 |
| Sortino ratio | 0.89 | 2.56 |
| Max drawdown | -35.5% | -26% |
| Current drawdown | -2.2% | -18.6% |
| Annualized volatility | 54.6% | 69.4% |
| Value at risk (95%) | -5% | -5.1% |
Straight answers
Each answer is regenerated from the current snapshot, not written once and left to age.
Which is better, RYTM or SEPN?
On the Algovestiq AIQ Score, SEPN is the stronger of the two as of Nov 15, 2026, scoring 69 against RYTM's 62. The edge comes from momentum and quality. RYTM is not without a case — it holds the better risk resilience profile, which matters more if that is the objective you are optimizing for. This is a systematic score, not a recommendation: it ranks the two on the same evidence, it does not know your holding period or tax position.
Is RYTM or SEPN the better buy right now?
SEPN carries the stronger systematic profile as of Nov 15, 2026, and the comparison is rated Fragile — 1 of 5 covered evidence groups agree. A Fragile rating means the conclusion is sensitive: only 1 of 5 covered evidence groups agree. Treat the lead as provisional.
Why does the AIQ Score favor SEPN over RYTM?
The composite weights Quality, Value, Momentum and Risk Resilience. SEPN leads Momentum by 15 points; SEPN leads Quality by 6 points; RYTM leads Risk Resilience by 5 points. Where the two split, the factor with the larger weight carries the result.
Which has more analyst upside, RYTM or SEPN?
Analyst price targets imply +18.5% upside for RYTM and not covered for SEPN. The model and the Street agree here, which is a broader base of evidence than either alone. Analyst targets are expectations, not predictions, and dispersion matters as much as the midpoint.
Which is better value, RYTM or SEPN?
Neither name separates on the peer-relative Value factor. The two are level on Value. The Value factor reads valuation relative to sector peers and to the company's own fundamental quality, so it is not the same as simply having the lower multiple.
Which has stronger growth, RYTM or SEPN?
RYTM on combined revenue and EPS growth. Growth here is measured on reported revenue and earnings, not on forward estimates — it describes what the businesses have delivered, not what the Street expects next.
Which has stronger momentum, RYTM or SEPN?
SEPN on the Momentum factor, by 15 points. Momentum is one of the four weighted factors in the AIQ composite. It has documented persistence over three- to twelve-month horizons, which makes it a timing input rather than a reason to hold something indefinitely.
Which is riskier, RYTM or SEPN?
RYTM is the more resilient of the two, so the other name carries the higher downside risk. RYTM on Risk Resilience, by 5 points. Risk Resilience is a weighted factor in the composite; position sizing usually responds to it more usefully than the buy/avoid decision does.
Is RYTM more profitable than SEPN?
The profitability evidence is mixed: gross margin 88.2% vs 99.6%; operating margin -66.7% vs -76.2%; ttm roe -20.5% vs -6.2%. RYTM leads on one measure and SEPN on two measures, and there is no single profitability composite that resolves the split — which of the two reads as "more profitable" depends on whether you weight pricing power or operating leverage.
Is SEPN's lead over RYTM getting stronger or weaker?
SEPN lead: Weakening — the AIQ differential moved from 19 to 7 points over 30 sessions. This is measured from 120 daily comparison snapshots between 2026-05-27 and 2026-11-13. The lead has not changed hands in that window.
What would change the RYTM vs SEPN verdict?
The result is a state, not a forecast, so it changes when the underlying evidence changes. Concretely: RYTM closes the Momentum gap — currently 15 points behind, the largest single contributor to SEPN's edge; RYTM's Death Cross Active resolves — a bearish trend rule currently active against it; SEPN's conflicting signal state resolves bearish — it currently carries 3 bullish and 3 bearish rules at once; the narrowing continues — the lead has already given back 12 points over 30 sessions, and a further 7-point move would eliminate SEPN's advantage entirely.
What do the current signals say about RYTM and SEPN?
RYTM: 3 bullish / 3 bearish / 2 neutral, conflicted. SEPN: 3 bullish / 3 bearish / 2 neutral, conflicted. A conflicted state means bullish and bearish rules are active on the same name at once — the technical evidence is not pointing one way, and a decision taken on it carries more timing risk. The most decision-relevant rule on RYTM is Death Cross Active (bearish, long horizon). On SEPN it is Golden Cross Active (bullish, long horizon).
Compare RYTM and SEPN with others
Continue your research
This page answers which of the two. These answer the questions on either side of it.
How this comparison is scored
The Algovestiq AIQ Score composites four factors — Quality, Value, Momentum and Risk, each carrying a fixed weight. Sentiment is reported separately as SentimentPulse and is not folded into the composite. Scores refresh every trading day, and this page regenerates from the latest snapshot rather than being written once.
The verdict names a leader, states how broadly six independent evidence groups agree, and rates how durable that conclusion is given the score gap, its recent trajectory and the current signal state on both names.
How to use side-by-side comparison →This comparison is informational and educational, not investment advice. AIQ scores update daily; re-check after earnings, guidance or macro data that materially changes either name’s factor profile.